Answers are grounded in this paper and cite their sources.
Transdermal administration of therapeutic ointments for cutaneous malignancies and severe localized bacterial infections is fundamentally constrained by the stratum corneum (SC) barrier. Here, we report a multi-modal transdermal drug delivery system comprising an electrospun piezoelectric Poly(vinylidene fluoride-trifluoroethylene)/Chitosan/Gold nanoparticle (P(VDF-TrFE)/CS/AuNP) membrane coupled with a custom-designed, multi-frequency ultrasonic excitation platform (1.0–3.0 MHz). The synthesized nanohybrid membrane exhibited superior biocompatibility, enhanced mechanical flexibility, and intrinsic acoustic impedance matching with human skin. FTIR and XRD analyses confirmed high 𝛽-phase crystallinity (82.4±1.8%) in the electrospun fibers, crucial for efficient electromechanical transduction. A custom dual-layer Printed Circuit Board (PCB) integrating an ATmega328P microcontroller and an AD9833 Direct Digital Synthesis (DDS) IC was fabricated to drive a PZT-5H ceramic transducer via an LC Butterworth impedance matching network. In vitro permeation tests using Franz diffusion cells demonstrated a 5.20±0.28-fold increase (𝑝<0.001, 𝑛=6) in the flux of a model oncology drug (5-Fluorouracil) across porcine skin under 2.4 MHz ultrasonic stimulation (1.2 W/cm2) compared to passive diffusion. Cytotoxicity assays (MTT) using L929 fibroblasts confirmed zero allergic response and 96.8±1.4% cell viability for the composite substrate. This integrative platform provides a non-invasive, highly controllable strategy for rapid local drug bio-absorption without systemic toxicity.
No takes yet. Share an insight, caveat, or question.
Shamo Salayev (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: